Moleculin Biotech (MBRX) Competitor Comparison
We are evaluating the key criteria listed to compare Moleculin Biotech (MBRX) against its competitors in the Biotechnology industry.
Market Capitalization
325 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
104 / 337Free Cashflow
125 / 352Quick Ratio
147 / 357Earnings per Share
342 / 359Dividend yield
0 / 6Total Cash
294 / 358Performance 3 years
120 / 368Performance 5 years
205 / 368Performance 10 years
306 / 368Linearity 3 years
33 / 368Linearity 5 years
197 / 368Linearity 10 years
309 / 367Total Rank
37 / 368Dividend Rank
211 / 368Valuation Rank
119 / 368Piotroski Rank
174 / 368Muliplier Rank
13 / 368Market Capitalization - MBRX ranking 325 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.